Here’s the release in full

This is the first time a government in Mexico has purchased CBD products for its citizens. The Mexican government’s move would be similar to Medicaid covering medical cannabis here in the states, and is a huge development in medical cannabis history. A report published in Health Affairs found that if all American states had legalized medical marijuana in 2014, Medicaid could have saved $1 billion in spending on prescriptions.

To mark the announcement, State of Mexico Governor Eruviel Avila distributed HempMeds Mexico’s flagship product Real Scientific Hemp Oil-X™ to the first 11 epilepsy and cancer patients at the inauguration of a new hospital in the State of Mexico on Thursday, August 17, 2017.


Numerous patients with neurological diseases, lung disease, epilepsy and other health problems have reported that they use fewer prescription medicines and have seen remarkable progress after using HempMeds products.

Nearly half of cannabidiol patients stop using traditional medicines according to a recent report on CBD oil user experience by Brightfield Group and HelloMD, who anticipate that the total cannabidiol market will reach $467 million in 2017.

Dr. Saul Garza Morales, pediatric researcher and neurologist in Mexico, recently shared the positive results of a recent study he conducted on the effects of Medical Marijuana, RSHO-X™ product in treating children with severe epilepsy, in which 86 percent of the 29 patients he studied experienced statistically significant (greater than 50%) reduction in motor seizures. Seventeen percent of the children were fully seizure free for a 4-month period.